Paper Key : IRJ************636
Author: Priyanka Patel,Prachi Patel,Nidhi Dana,Bhakti Patel
Date Published: 02 Jul 2024
Abstract
A complex relationship between viral infection and cardiovascular health, particularly in connection to myocardial infarction (MI) or heart attacks, has been highlighted by the COVID-19 pandemic. The respiratory tract, not the heart, is the target of the seven human corona viruses that are now known to exist. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is recent corona virus which also affect the heart. It can cause myocarditis, which is an inflammation of the heart, cell necrosis, arrhythmias, and either acute or chronic heart failure, which is caused by muscle dysfunction. These problems have happened even in cases with minor symptoms and in those who did not experience any symptoms. Among many other places, we thoroughly searched PubMed and Google Scholar. In order to clarify the complex link between COVID-19 and MI, this review looks at recent research, covering topics such as underlying pathophysiological mechanisms, clinical updates on cardiovascular manifestation of covid-19, adverse effects of COVID-19 in relation to MI, diagnostic challenges and strategies in covid-19 with MI and therapeutic approaches. After mRNA COVID-19 vaccinations, a no of systemic and local adverse effects have been seen. Myocarditis, pericarditis, and myocardial infarction have been linked with these vaccinations. Acute coronary syndrome treatment has been impacted at every stage by the COVID-19 pandemic, which has placed an unparalleled amount of strain on healthcare systems. COVID-19 not only increasing the risk of heart problems but also has a direct effect on its tissue through hypercoagulability, systemic inflammation and also endothelial dysfunction. It is imperative to comprehend these pathways in order to promptly identify and treat MI in COVID-19 patients. The study also examines therapeutic issues and identifies information gaps, promoting ongoing research to improve clinical outcomes in this susceptible population. Unfortunately, a wide range of clinical indications of multisystem dysfunction, including pulmonary embolism, deep vein thrombosis, acute myocardial infarction, depression, anxiety, myalgia, dyspnea, and fatigue, may still be reported by recovered COVID-19 survivors.